Navigation Links
Almac Doubles Capacity at North Carolina Facility
Date:11/17/2009

The Almac Group has completed a 67,000 square foot expansion to their North Carolina facility in Durham, which now houses both the Clinical Services and Diagnostics Divisions. This additional facility , along with existing capacity, will increase the Durham campus to almost 138,000 square feet and provide 3,000 extra pallet locations for clinical supplies storage requirements.

(PRWEB) November 17, 2009 -- The Almac Group has completed a 67,000 square foot expansion to their North Carolina facility in Durham, which now houses both the Clinical Services and Diagnostics Divisions. Almac Clinical Services first began occupancy of the additional building on the campus in February 2008 and have since added a 30,000 square foot warehouse complete with two new loading docks. Staff from Almac Diagnostics’ nearby facility in Durham have relocated to the site and are engaged in research activity across a wide-range of projects.

This expansion has greatly increased storage capacity for clinical supplies with an additional 3,000 pallet locations and is part of global growth across the Almac Group in recent months. This includes the completion of a specialist clinical supplies storage facility in Craigavon, U.K. and the ongoing development of a 240,000 square foot North American headquarters facility in Pennsylvania on target for completion in 2010. This new facility will initially house Clinical Services and Clinical Technologies operations with expansion from other divisions in the Almac Group.

The new facility in Durham, NC was built to accommodate increased demand in outsourcing of clinical supply management services from Biotech and Pharma organisations. It will also ensure that synergies between Clinical Services and Diagnostics are fully realised for the benefit of clients. This additional facility, along with existing capacity, will increase the Durham campus to almost 138,000 square feet; more than double the size of their original operations.

Donna Christopher, Vice President of Operations at Almac Clinical Services, Durham site said: “This latest investment by Almac will act as a platform for us to serve the increasing demands of our client base who are seeking faster routes to get their products through the clinical development process. We now have 200 employees at our North Carolina operations which is more than five times the number we had when we first started out in 1998 with a team of 35. With over 20 years experience in clinical supply management Almac are recognised as a strategic partner in the clinical supply process by most of the world’s pharma and biotech companies. This increase in capacity is a sign of our commitment to offer market driven solutions to our customers.”

To view more pictures go to: http://www.flickr.com/photos/almac_clinical_services/

About Almac

Almac is a financially stable, privately owned organisation with over 30 years experience, it provides integrated development solutions to over 600 customers worldwide including all the world leaders in the pharmaceutical and biotechnology sectors. Their services include R&D , translational genomic services; API manufacture; formulation development; clinical trial supply and technology (IVRS/ IWRS/ ePRO) and commercial- scale manufacture.

The company has over 2,500 employees and is headquartered in Craigavon, Northern Ireland, where it was awarded "Business of the Year 2009". US operations are based in Pennsylvania, North Carolina and California. Construction of the company's new $120m North American Headquarters in PA started in July 08 and will be completed in 2010. For more information about the Almac Group, please visit www.almacgroup.com or e-mail info(at)almacgroup.com

###

Read the full story at http://www.prweb.com/releases/Durhamexpansion/AlmacClinicalServices/prweb3211584.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Associated Builders & Contractors, Inc. Launches Campaign Against Discriminatory Practices of Almac and Skanska USA
2. Stroke Doubles Risk of Hip, Thigh Fractures
3. Pre-cessation patch doubles quit success rate: Researchers call for labeling changes
4. Decho Doubles Number of Mozy Healthcare Customers
5. Three Drinks a Day Doubles Risk of Tremor
6. Gene Mutation Doubles Risk of Aggressive Colon Cancer in Blacks
7. 2 Hours Glued to TV Doubles Kids Asthma Risk
8. Early Menopause Doubles Stroke Risk
9. Family History of Melanoma Doubles Parkinsons Risk
10. AmeriCares Doubles Aid to Zimbabwe
11. ReBuilder Medical (RBRM) Neuropathy Market Doubles to $5 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Almac Doubles Capacity at North Carolina Facility
(Date:2/12/2016)... ... February 12, 2016 , ... Erlanger Agency has announced a new ... area. The latest campaign focuses on the fight against breast cancer, fundraising for a ... accepted here . , Carmen is a loving single mother of two boys ...
(Date:2/12/2016)... San Ramon, CA (PRWEB) , ... February 12, 2016 , ... ... tissue donation in northern California and Nevada, announced a partnership with San Ramon Regional ... be transferred to the hospital’s facilities as a way to accommodate a more certain ...
(Date:2/12/2016)... FL (PRWEB) , ... February 12, 2016 , ... For ... Dental hygienist Suzan Sweeney, RDH, and dental assistant Terrell Moore shortly before 7 a.m. ... joined dozens of dental professionals, donating their time and skills to help hundreds of ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... “Revolutionizing Cancer Care.” , The print component of “Revolutionizing Cancer Care” ... Pittsburgh/Cleveland, New York, Washington DC/Baltimore, and Seattle, with a circulation of approximately 250,000 ...
(Date:2/12/2016)... ... 12, 2016 , ... Atlantic Information Services, Inc. (AIS) is ... an upcoming Feb. 24 webinar that will discuss ways health plans and PBMs ... as the $1,000-per-pill hepatitis C treatment Sovaldi and high-cost PCSK9 inhibitors to treat ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Ky. , Feb. 12, 2016 /PRNewswire/ ... has completed a $47.1 million Series D ... Cormorant Asset Management, Hillhouse Capital Group and ... Morningside Venture Investments, AJU IB Investment, and ... be used to further advance clinical trials ...
(Date:2/11/2016)... The primary goal of this research is ... the usage of liquid biopsy. Key information the survey ... Timeframe of liquid biopsy adoption amidst future users - ... type - Sample inflow to conduct liquid biopsy tests ... and so on. - Correlation analysis of sample type ...
(Date:2/11/2016)... Feb. 11, 2016  Kindred Biosciences, Inc. (NASDAQ: ... improving the lives of pets, today announced the submission ... New Animal Drug Application (NADA) for Zimeta™ (dipyrone injection, ... (KB0120) of Zimeta for the control of pyrexia (fever) ... --> --> The Chemistry, ...
Breaking Medicine Technology: